APA (7th ed.) Citation

Wrobel, J., Najafi, S., Ayhan, S., Gatzweiler, C., Krunic, D., Ridinger, J., . . . Oehme, I. (2020). Rapid in vivo validation of HDAC inhibitor-based treatments in neuroblastoma zebrafish xenografts. Pharmaceuticals, 13(11), . https://doi.org/10.3390/ph13110345

Chicago Style (17th ed.) Citation

Wrobel, Jagoda, et al. "Rapid in Vivo Validation of HDAC Inhibitor-based Treatments in Neuroblastoma Zebrafish Xenografts." Pharmaceuticals 13, no. 11 (2020). https://doi.org/10.3390/ph13110345.

MLA (9th ed.) Citation

Wrobel, Jagoda, et al. "Rapid in Vivo Validation of HDAC Inhibitor-based Treatments in Neuroblastoma Zebrafish Xenografts." Pharmaceuticals, vol. 13, no. 11, 2020, https://doi.org/10.3390/ph13110345.